Literature DB >> 27996178

Quantitative Analysis of Extracranial Arterial Tortuosity in Patients with Sickle Cell Disease.

Karen Buch1, Rahul Arya1, Bhavya Shah1, Rohini N Nadgir1, Naoko Saito1, Muhammad M Qureshi1,2, Osamu Sakai1,2,3.   

Abstract

PURPOSE: Compared to the intracranial vasculature in sickle cell disease (SCD) patients, the morphologic changes of the extracranial vasculature in SCD patients are less well understood. The purpose of this study was to evaluate the tortuosity of the extracranial carotid and vertebral arteries in patients with SCD compared to age-matched controls.
METHODS: Following Institution Review Board approval, between January 2004 and December 2013, Magnetic resonance angiogram neck examinations were retrospectively reviewed on 56 patients with SCD and 56 age-matched controls. Vessel tortuosity was measured as curved vector lengths in the common carotid, extracranial internal carotid, and vertebral arteries bilaterally. Correlation of vessel tortuosity with age and hematocrit level was assessed. Paired and unpaired Student's t-tests were performed to determine within and between group differences.
RESULTS: Greater tortuosity in extracranial carotid and vertebral arteries were noted in patients with SCD as compared to age-matched control patients (P < .001). Greater differences in tortuosity between carotid and vertebral arteries were noted in SCD patients as compared to differences in control patients. Incidence of infarction was significantly associated with greater tortuosity of right carotid (P = .002), right (P = .004), and left (P = .020) vertebral arteries.
CONCLUSIONS: Extracranial carotid and vertebral arterial tortuosity is increased in SCD patients. This could be related to aberrations in hemodynamics from nonlaminar flow in these vessels. These increases in extracranial vascular tortuosity could potentially lead to alterations in intracranial vascular tortuosity and may be an independent risk factor for cerebral infarct.
Copyright © 2016 by the American Society of Neuroimaging.

Entities:  

Keywords:  Sickle cell disease; magnetic resonance angiography; vessel tortuosity

Mesh:

Year:  2016        PMID: 27996178     DOI: 10.1111/jon.12418

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  6 in total

1.  Sickle Cell Anemia Mediates Carotid Artery Expansive Remodeling That Can Be Prevented by Inhibition of JNK (c-Jun N-Terminal Kinase).

Authors:  Hannah Song; Philip M Keegan; Suhaas Anbazhakan; Christian P Rivera; Yundi Feng; Victor O Omojola; Alexus A Clark; Shuangyi Cai; Jada Selma; Rudolph L Gleason; Edward A Botchwey; Yunlong Huo; Wenchang Tan; Manu O Platt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-12       Impact factor: 8.311

2.  An Experimental-Computational Approach to Quantify Blood Rheology in Sickle Cell Disease.

Authors:  Marisa S Bazzi; José M Valdez; Victor H Barocas; David K Wood
Journal:  Biophys J       Date:  2020-10-20       Impact factor: 4.033

3.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

4.  Incidence, kinetics, and risk factors for intra- and extracranial cerebral arteriopathies in a newborn sickle cell disease cohort early assessed by transcranial and cervical color Doppler ultrasound.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Fouad Madhi; Camille Jung; Ralph Epaud; Suzanne Verlhac
Journal:  Front Neurol       Date:  2022-09-14       Impact factor: 4.086

5.  Systemic Arterial Correlates of Cervical Carotid Artery Tortuosity : The Northern Manhattan Study.

Authors:  Farid Khasiyev; Tatjana Rundek; Marco R Di Tullio; Clinton B Wright; Ralph L Sacco; Mitchell S V Elkind; Jose Gutierrez
Journal:  Clin Neuroradiol       Date:  2021-06-16       Impact factor: 3.156

6.  MRI detection of brain abnormality in sickle cell disease.

Authors:  Hanne Stotesbury; Jamie Michelle Kawadler; Dawn Elizabeth Saunders; Fenella Jane Kirkham
Journal:  Expert Rev Hematol       Date:  2021-06-07       Impact factor: 2.929

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.